The Thrombospondin-1 Mimetic ABT-510 Increases the Uptake and Effectiveness of Cisplatin and Paclitaxel in a Mouse Model of Epithelial Ovarian Cancer
Epithelial ovarian cancer (EOC) comprises approximately 90% of ovarian cancers and arises from the surface epithelium. Typical treatment of EOC involves cytoreductive surgery combined with chemotherapy. More recent therapies have targeted the tumor vasculature using antiangiogenic compounds such as...
Main Authors: | Nicole E. Campbell, James Greenaway, Jack Henkin, Roger A. Moorehead, Jim Petrik |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2010-03-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S147655861080106X |
Similar Items
-
The use of Thrombospondin-1 Mimetic Peptides for the Treatment of Epithelial Ovarian Cancer
by: Campbell, Nicole
Published: (2012) -
The BH3 mimetic ABT-737 increases treatment efficiency of paclitaxel against hepatoblastoma
by: Fuchs Jörg, et al.
Published: (2011-08-01) -
The Role of Dysregulated Glucose Metabolism in Epithelial Ovarian Cancer
by: L. D. Kellenberger, et al.
Published: (2010-01-01) -
Endothelial Cell Behavior Is Determined by Receptor Clustering Induced by Thrombospondin-1
by: Verônica Morandi, et al.
Published: (2021-03-01) -
Effects of paclitaxel and cisplatin on in vitro ovarian follicle development
by: Yoon Kim, et al.
Published: (2019-01-01)